Turning negatives into positives: Clearing up clinical trials misconceptions
This Clinical Trials Awareness Day, we’re exploring lessons from clinical trials and debunking clinical trials misconceptions.
Celiac disease and type 1 diabetes: What’s the connection?
What is the link between celiac disease and type 1 diabetes? Learn what celiac disease is, how it is treated, and its connection to T1D.
The current state of mental and emotional health care for people with T1D
T1D management is demanding, and it can take a toll on mental health. Providing psychosocial support is key to our Improving Lives work.
New Breakthrough T1D publications highlight unmet needs and demographics of the T1D population
Breakthrough T1D recently published two peer-reviewed journal articles. One detailed burdensome unmet needs in the T1D community and identified key steps we can take to meet these needs. The other used real-world data to better understand American T1D demographics and predict changes in the next decade.
New video game teaches type 1 diabetes management
Breakthrough T1D Play partnered with video game company Level Ex to create an app-based game that teaches the basics of type 1 diabetes management.
Type 1 diabetes vs. type 2 diabetes
Though they share some similarities, type 1 diabetes (T1D) and type 2 diabetes (T2D) have different causes, effects, and treatments.
Adam Singer: An innovative volunteer and fundraising leader
The Breakthrough T1D Real Estate Games is sponsored by the commercial real estate community to benefit type 1 diabetes research.
Pat McFeeley: Thinking big for cures
For Pat McFeeley, Breakthrough T1D Ride is a great example of bringing people together to make a difference for people living with T1D.
Riding coast to coast for cures
Matt Varey, a key volunteer with Breakthrough T1D, will embark on a two-month-long, 7,500 km cycling journey across Canada to fundraise for the type 1 diabetes community.
A behind-the-scenes look at DIAGNODE-3: Phase 3 clinical trials of Diamyd® for T1D
DIAGNODE-3 is a phase 3 clinical trial of the disease-modifying therapy Diamyd® that aims to preserve insulin-producing beta cells.
